IFN-γ: A Crucial Player in the Fight Against HBV Infection?

키워드

참고문헌 (96)

1. Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections, "World Health Organization", World Health Organization, ~ (2021)
2. Ye J, "Interferon and hepatitis B : current and future perspectives", Front Immunol, 12, pp.733364~ (2021)
3. Fanning GC, "Therapeutic strategies for hepatitis B virus infection : towards a cure", Nat Rev Drug Discov, 18, pp.827~844 (2019)
4. Vaillant A, "HBsAg, subviral particles, and their clearance in establishing a functional cure of chronic hepatitis B virus infection", ACS Infect Dis, 7, pp.1351~1368 (2021)
5. Vaillant A, "Oligonucleotide-based therapies for chronic HBV infection : a primer on biochemistry, mechanisms and antiviral effects", Viruses, 14, pp.2052~ (2022)
6. Ganchua SC, "Reduction of hepatitis B surface antigen mediated by RNA interference therapeutic AB-729 in chronic hepatitis B patients is associated with T cell activation and a decline in exhausted CD8 T cells", J Hepatol, 77, pp.S851~ (2022)
7. Yuen MF, "Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B : a phase 2 randomized controlled trial", Nat Med, 27, pp.1725~1734 (2021)
8. Beretta M, "Advances in human monoclonal antibody therapy for HBV infection", Curr Opin Virol, 53, pp.101205~ (2022)
9. MacMicking JD, "Interferon-inducible effector mechanisms in cell-autonomous immunity", Nat Rev Immunol, 12, pp.367~382 (2012)
10. Lee AJ, "The dual nature of type I and type II interferons", Front Immunol, 9, pp.2061~ (2018)
11. Jorgovanovic D, "Roles of IFN-γ in tumor progression and regression : a review", Biomark Res, 8, pp.49~ (2020)
12. Schoggins JW, "Interferon-stimulated genes : what do they all do?", Annu Rev Virol, 6, pp.567~584 (2019)
13. Wang J, "Advances in Experimental Medicine and Biology", pp.17~37 (2020), Springer Singapore
14. Tsukuda S, "Hepatitis B virus biology and life cycle", Antiviral Res, 182, pp.104925~ (2020)
15. Li L, "Association between the interferon-γ +874T", A polymorphism and susceptibility to hepatitis B virus infection : a meta-analysis, 2020, pp.48, 300060520945511~
16. Xu J, "Human genetic susceptibility to hepatitis B virus infection", Infect Genet Evol, 87, pp.104663~ (2021)
17. Schena FP, "Role of interferon-gamma gene polymorphisms in susceptibility to IgA nephropathy : a family-based association study", Eur J Hum Genet, 14, pp.488~496 (2006)
18. Zhao J, "Natural killer cells are characterized by the concomitantly increased interferon-γ and cytotoxicity in acute resolved hepatitis B patients", PLoS One, 7, pp.e49135~ (2012)
19. Ben Selma W, "Association of an IFN-γ variant with susceptibility to chronic hepatitis B by the enhancement of HBV DNA replication", Cytokine, 143, pp.155525~ (2021)
20. Dondeti MF, "Association between interferon-gamma(IFN-γ)gene polymorphisms(+874A", T and +2109A, J Appl Biomed, pp.2022, 20[DOI]
21. Wang Q, "A single nucleotide polymorphism of the interferon-γ gene and susceptibility to hepatitis B virus-related cirrhosis : a randomized controlled trial", Int J Clin Exp Pathol, 11, pp.4140~4146 (2018)
22. Guidotti LG, "Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes", Immunity, 4, pp.25~36 (1996)
23. Kakimi K, "Natural killer T cell activation inhibits hepatitis B virus replication in vivo", J Exp Med, 192, pp.921~930 (2000)
24. Webster GJ, "Incubation phase of acute hepatitis B in man : dynamic of cellular immune mechanisms", Hepatology, 32, pp.1117~1124 (2000)
25. Fisicaro P, "Early kinetics of innate and adaptive immune responses during hepatitis B virus infection", Gut, 58, pp.974~982 (2009)
26. Li Y, "Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B", PLoS One, 9, pp.e86927~ (2014)
27. Zhou Y, "The characteristics of natural killer cells and T cells vary with the natural history of chronic hepatitis B in children", Front Pediatr, 9, pp.736023~ (2021)
28. Gu Y, "Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B", BMC Infect Dis, 20, pp.509~ (2020)
29. Yang Y, "Hepatitis B virus antigens impair NK cell function", Int Immunopharmacol, 38, pp.291~297 (2016)
30. Ma Q, "Hepatitis B e antigen induces NKG2A+ natural killer cell dysfunction via regulatory T cell-derived interleukin 10 in chronic hepatitis B virus infection", Front Cell Dev Biol, 8, pp.421~ (2020)
31. De Pasquale C, "Human hepatitis B virus negatively impacts the protective immune crosstalk between natural killer and dendritic cells", Hepatology, 74, pp.550~565 (2021)
32. Yang Z, "Type 1 innate lymphoid cells contribute to the pathogenesis of chronic hepatitis B", Innate Immun, 21, pp.665~673 (2015)
33. Thimme R, "CD8(+)T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection", J Virol, 77, pp.68~76 (2003)
34. Wang H, "TNF-α", IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection, 2020, pp.72, 45~56
35. Wieland SF, "Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees", Proc Natl Acad Sci U S A, 101, pp.2129~2134 (2004)
36. Xia Y, "Interferon-γ and tumor necrosis factor-α produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis", Gastroenterology, 150, pp.194~205 (2016)
37. Hayashi Y, "Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA", J Virol, 63, pp.2936~2940 (1989)
38. Nosaka T, "Molecular signature of hepatitis B virus regulation by interferon-γ in primary human hepatocytes", Hepatol Res, 50, pp.292~302 (2020)
39. Parvez MK, "Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-γ", World J Gastroenterol, 12, pp.3006~3014 (2006)
40. Pasquetto V, "Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures", J Virol, 76, pp.5646~5653 (2002)
41. Xu C, "Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus", J Virol, 84, pp.9332~9340 (2010)
42. McClary H, "Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines", J Virol, 74, pp.2255~2264 (2000)
43. Mao R, "Indoleamine 2, 3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells", J Virol, 85, pp.1048~1057 (2011)
44. Zhang Z, "Hepatitis B virus particles activate Toll-like receptor 2 signaling initially upon infection of primary human hepatocytes", Hepatology, 72, pp.829~844 (2020)
45. Huang B, "Global characterization of interferon regulatory factor(IRF)genes in vertebrates : glimpse of the diversification in evolution", BMC Immunol, 11, pp.22~ (2010)
46. Yamane D, "Basal expression of interferon regulatory factor 1 drives intrinsic hepatocyte resistance to multiple RNA viruses", Nat Microbiol, 4, pp.1096~1104 (2019)
47. Cesaro T, "Inhibition of PKR by viruses", Front Microbiol, 12, pp.757238~ (2021)
48. Gusho E, "New advances in our understanding of the"unique"RNase L in host pathogen interaction and immune signaling", Cytokine, 133, pp.153847~ (2020)
49. Guidotti LG, "Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice", J Virol, 76, pp.2617~2621 (2002)
50. Sadeghpour S, "Human APOBEC3 variations and viral infection", Viruses, 13, pp.1366~ (2021)
51. Proto S, "APOBEC and iNOS are not the main intracellular effectors of IFN-γ-mediated inactivation of hepatitis B virus replication", Antiviral Res, 78, pp.260~267 (2008)
52. Turelli P, "Inhibition of hepatitis B virus replication by APOBEC3G", Science, 303, pp.1829~1829 (2004)
53. Nguyen DH, "Reverse transcriptase-and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids", J Virol, 82, pp.6852~6861 (2008)
54. Yoshio S, "Indoleamine-2, 3-dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B", Hepatology, 63, pp.83~94 (2016)
55. Nguyen LH, "The human interferon-and estrogen-regulated ISG20", HEM45 gene product degrades single-stranded RNA and DNA in vitro, 2001, pp.40, 7174~7179
56. Stadler D, "Interferon-induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20", EMBO Rep, 22, pp.e49568~ (2021)
57. Park YK, "Antiviral activity of interferon-stimulated gene 20, as a putative repressor binding to hepatitis B virus enhancer II and core promoter", J Gastroenterol Hepatol, 35, pp.1426~1436 (2020)
58. Imam H, "Interferon-stimulated gene 20(ISG20)selectively degrades N6-methyladenosine modified hepatitis B virus transcripts", PLoS Pathog, 16, pp.e1008338~ (2020)
59. Leong CR, "Interferon-stimulated gene of 20 kDa protein(ISG20)degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo", Oncotarget, 7, pp.68179~68193 (2016)
60. Liu Y, "Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA", PLoS Pathog, 13, pp.e1006296~ (2017)
61. Braun E, "Guanylate-binding proteins 2 and 5 exert broad antiviral activity by inhibiting furin-mediated processing of viral envelope proteins", Cell Reports, 27, pp.2092~2104 (2019)
62. Messageot F, "Proteolytic processing of the hepatitis B virus e antigen precursor. Cleavage at two furin consensus sequences", J Biol Chem, 278, pp.891~895 (2003)
63. Yang HY, "Entecavir combined with furin inhibitor simultaneously reduces hepatitis B virus replication and e antigen secretion", Virol J, 11, pp.165~ (2014)
64. Wu JF, "Suppression of furin by interferon-γ and the impact on hepatitis B virus antigen biosynthesis in human hepatocytes", Am J Pathol, 181, pp.19~25 (2012)
65. Santos JC, "Sensing of invading pathogens by GBPs : at the crossroads between cell-autonomous and innate immunity", J Leukoc Biol, 104, pp.729~735 (2018)
66. Chen J, "Functional comparison of interferon-α subtypes reveals potent hepatitis B virus suppression by a concerted action of interferon-α and interferon-γ signaling", Hepatology, 73, pp.486~502 (2021)
67. Shi H, "Increased apoptosis in HepG2.2.15 cells with hepatitis B virus expression by synergistic induction of interferon-γ and tumour necrosis factor-α", Liver Int, 29, pp.349~355 (2009)
68. Tretina K, "Interferon-induced guanylate-binding proteins : guardians of host defense in health and disease", J Exp Med, 216, pp.482~500 (2019)
69. Wieland S, "Genomic analysis of the host response to hepatitis B virus infection", Proc Natl Acad Sci U S A, 101, pp.6669~6674 (2004)
70. Shin GC, "Hepatocystin contributes to interferon-mediated antiviral response to hepatitis B virus by regulating hepatocyte nuclear factor 4α", Biochim Biophys Acta, 1842, pp.1648~1657 (2014)
71. Shin GC, "Hepatocystin", 80K-H inhibits replication of hepatitis B virus through interaction with HBx protein in hepatoma cell, 2013, pp.1832, 1569~1581
72. Yu X, "Distinct modes of regulation of transcription of hepatitis B virus by the nuclear receptors HNF4α and COUP-TF1", J Virol, 77, pp.2489~2499 (2003)
73. Kim DH, "Intracellular interleukin-32γ mediates antiviral activity of cytokines against hepatitis B virus", Nat Commun, 9, pp.3284~ (2018)
74. Shen Z, "The roles of TRIMs in antiviral innate immune signaling", Front Cell Infect Microbiol, 11, pp.628275~ (2021)
75. Gao B, "Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain", Hepatology, 50, pp.424~433 (2009)
76. Carreño V, "Alpha-and gamma-interferon versus alpha-interferon alone in chronic hepatitis B. A randomized controlled study", J Hepatol, 17, pp.321~325 (1993)
77. Di Bisceglie AM, "Therapy of chronic hepatitis B with recombinant human alpha and gamma interferon", Hepatology, 11, pp.266~270 (1990)
78. Kakumu S, "Treatment with human gamma interferon of chronic hepatitis B : comparative study with alpha interferon", J Med Virol, 35, pp.32~37 (1991)
79. Marcellin P, "Recombinant human γ-interferon in patients with chronic active hepatitis B : pharmacokinetics, tolerance and biological effects", Hepatology, 12, pp.155~158 (1990)
80. Wu YJ, "Long-term antifibrotic action of interferon-γ treatment in patients with chronic hepatitis B virus infection", Hepatobiliary Pancreat Dis Int, 10, pp.151~157 (2011)
81. Lau JY, "A randomised controlled trial of recombinant interferon-gamma in Chinese patients with chronic hepatitis B virus infection", J Med Virol, 34, pp.184~187 (1991)
82. Bissett J, "Recombinant fibroblast interferon and immune interferon for treating chronic hepatitis B virus infection : patients’ tolerance and the effect on viral markers", J Infect Dis, 157, pp.1076~1080 (1988)
83. Carreno V, "Combination of recombinant interferons alpha and gamma in treatment of chronic hepatitis B", Lancet, 2, pp.1086~ (1987)
84. Caselmann WH, "Beta-and gamma-interferon in chronic active hepatitis B. A pilot trial of short-term combination therapy", Gastroenterology, 96, pp.449~455 (1989)
85. Brunelle MN, "Inhibition of hepatitis B virus DNA replication by a thermostable interferon-γ variant", Antivir Ther, 15, pp.861~869 (2010)
86. Cornberg M, "Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡", J Hepatol, 72, pp.539~557 (2020)
87. Yuan W, "Pegylated interferon-α(IFN-α)enhances the inhibitory effect of natural killer cells on regulatory T cells via IFN-γ in chronic hepatitis B", J Infect Dis, 224, pp.1878~1889 (2021)
88. Liu L, "PD-L1 upregulation by IFN-α", γ-mediated Stat1 suppresses anti-HBV T cell response, 2020, pp.15, e0228302~
89. Zeng Z, "Interferon-γ facilitates hepatic antiviral T cell retention for the maintenance of liver-induced systemic tolerance", J Exp Med, 213, pp.1079~1093 (2016)
90. Weng HL, "IFN-γ inhibits liver progenitor cell proliferation in HBV-infected patients and in 3, 5-diethoxycarbonyl-1, 4-dihydrocollidine diet-fed mice", J Hepatol, 59, pp.738~745 (2013)
91. Li J, "IFN-γ facilitates liver fibrogenesis by CD161+CD4+ T cells through a regenerative IL-23", IL-17 axis in chronic hepatitis B virus infection, 2021, pp.10, e1353~
92. Chen Y, "Natural killer cell-derived interferon-gamma promotes hepatocellular carcinoma through the epithelial cell adhesion molecule-epithelial-to-mesenchymal transition axis in hepatitis B virus transgenic mice", Hepatology, 69, pp.1735~1750 (2019)
93. Zhao C, "The therapeutic effect of IL-21 combined with IFN-γ inducing CD4+CXCR5+CD57+T cells differentiation on hepatocellular carcinoma", J Adv Res, 36, pp.89~99 (2021)
94. Wu HL, "Liver gene expression profiles correlate with virus infection and response to interferon therapy in chronic hepatitis B patients", Sci Rep, 6, pp.31349~ (2016)
95. Takagi K, "High TSC22D3 and low GBP1 expression in the liver is a risk factor for early recurrence of hepatocellular carcinoma", Exp Ther Med, 2, pp.425~431 (2011)
96. Britzen-Laurent N, "GBP-1 acts as a tumor suppressor in colorectal cancer cells", Carcinogenesis, 34, pp.153~162 (2013)

관련 논문AI추천